Board approved re-appointment of Vishal Sharma as Executive Director & CEO (Chemicals) from April 2027 to March 2030, subject to shareholder approval.
Approved raising up to ₹1,500 crore via unsecured NCDs/bonds in one or more tranches over one year, subject to shareholder consent.
Approved further investment of up to ₹1,000 crore in wholly-owned subsidiary Godrej Investment Limited, exceeding statutory limits.